MARKET

KHTRF

KHTRF

Knight Therapeut
OTCPK
7.40
+0.44
+6.32%
Opening 10:20 07/01 EDT
OPEN
7.40
PREV CLOSE
6.96
HIGH
7.40
LOW
7.40
VOLUME
325
TURNOVER
2.40K
52 WEEK HIGH
7.40
52 WEEK LOW
4.220
MARKET CAP
726.35M
P/E (TTM)
179.18
1D
5D
1M
3M
1Y
5Y
1D
Knight Therapeutics Announces Repayment of Revolving Credit Facility
Barchart · 06/17 16:30
Knight Announces Early Warning Filing Regarding Shares of Crescita
Barchart · 06/05 17:00
Knight to Present at the Jefferies 2026 Healthcare Conference in New York City
Barchart · 05/28 06:30
Knight to Present at the 2026 RBC Capital Markets Global Healthcare Conference in New York City
Barchart · 05/12 05:30
Analyst Lifts Knight Therapeutics Price Target to $12 on Strong Outperformance and Upgraded 2026 Outlook, Reiterates Buy Rating
TipRanks · 05/10 07:45
Knight Therapeutics price target raised to C$9.50 from C$8.50 at RBC Capital
TipRanks · 05/08 20:29
Knight Therapeutics resumed with a Buy at Canaccord
TipRanks · 05/08 20:12
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Knight Therapeutics (OtherKHTRF) and TScan Therapeutics (TCRX)
TipRanks · 05/08 18:40
More
About KHTRF
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company monitors investments in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by the Company such as Exelon and Impavido.

Webull offers Knight Therapeutics Inc stock information, including OTCPK: KHTRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KHTRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KHTRF stock methods without spending real money on the virtual paper trading platform.